Rasna Therapeutics, Inc.

RASP | PNK | 0 Sledující

$0.0040

0.00%

$0.00

Sledovat

Overview Metrics Financials

Breakdown	9/30/2023 USD	9/30/2022 USD	9/30/2021 USD
Total revenue	0 -	0 -	0 -
Cost of revenue	0 -	0 -100.00%	0 -
Gross profit	0 -	0 +100.00%	-0 -
Operating expense	4,238 +1,004.01%	384 +54.92%	248 -
Operating income	-4,238 -3,104.09%	141 +156.93%	-248 -
Pretax Income	-4,443 -547.05%	-687 +12.55%	-785 -
Tax Provision	0 +100.00%	-113 -121.96%	516 -
Net income	-4,443 -674.95%	-573 +55.94%	-1,301 -
EPS	-0.01 -50.98%	-0.01 +73.02%	-0.02 -
Diluted EPS	-0.01 -50.98%	-0.01 +73.02%	-0.02 -
Average Shares	578,017 +418.75%	111,426 +61.70%	68,908 -
Diluted Average Shares	578,017 +418.75%	111,426 +61.70%	68,908 -
EBIT	-4,230 -1,762.53%	254 +170.65%	-360 -
EBITDA	-380 -249.22%	254 +202.79%	-248 -

Soubory cookie používáme ke zlepšení prohlížení na webu.